CIK 0000924717
SRDX SURMODICS INC
Insider trading from SEC Form 4. Last filing Nov 19, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Signals
Open-market buys and sells at SURMODICS INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Timothy J. Arens Chief Financial Officer sell | $276k 7,009 shares | -9% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 26, 2024 | TIMOTHY ARENS Officer | 7,009 0.05% of outstanding | $276k | Nov 26, 2024 | none |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Joseph J. Stich SVP of HR, President IVD | DDisposition to issuer Common Stock | -61,631 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Jose H Bedoya director | DDisposition to issuer Common Stock | -30,008 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Susan E Knight director | DDisposition to issuer Common Stock | -37,240 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | David Dantzker director | DDisposition to issuer Common Stock | -40,183 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Common Stock | -51,478 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | John D. Manders VP Finance, Corp. Controller | DDisposition to issuer Common Stock | -8,155 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Common Stock | -67,299 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Lisa Wipperman Heine director | DDisposition to issuer Common Stock | -13,978 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Common Stock | -34,703 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gordon S. Weber Sr. VP of Legal, GC and Sec. | DDisposition to issuer Common Stock | -21,040 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gary R Maharaj President & CEO | DDisposition to issuer Common Stock | -192,056 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Lisa Wipperman Heine director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -2,605 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | John D. Manders VP Finance, Corp. Controller | DDisposition to issuer Employee Stock Option (right to buy)derivative | -1,740 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gordon S. Weber Sr. VP of Legal, GC and Sec. | DDisposition to issuer Employee Stock Options (right to buy)derivative | -11,538 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | David Dantzker director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -2,605 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Joseph J. Stich SVP of HR, President IVD | DDisposition to issuer Employee Stock Option (right to buy)derivative | -12,292 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gary R Maharaj President & CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -45,073 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Jose H Bedoya director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -2,605 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Common Stockindirect: By IRA | -800 | - | - | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Employee Stock Option (right to buy)derivative | -10,653 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Option (right to buy)derivative | -5,463 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Susan E Knight director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,634 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Joseph J. Stich SVP of HR, President IVD | DDisposition to issuer Employee Stock Option (right to buy)derivative | -15,668 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Jose H Bedoya director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,218 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | David Dantzker director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,218 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | John D. Manders VP Finance, Corp. Controller | DDisposition to issuer Employee Stock Option (right to buy)derivative | -1,862 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Susan E Knight director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,548 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Employee Stock Option (right to buy)derivative | -2,615 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Lisa Wipperman Heine director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,218 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Employee Stock Option (right to buy)derivative | -10,653 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gordon S. Weber Sr. VP of Legal, GC and Sec. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -17,883 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gary R Maharaj President & CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -62,674 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Option (right to buy)derivative | -12,292 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Employee Stock Option (right to buy)derivative | -15,668 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Susan E Knight director | DDisposition to issuer Employee Stock Options (right to buy)derivative | -3,196 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Joseph J. Stich SVP of HR, President IVD | DDisposition to issuer Employee Stock Options (right to buy)derivative | -17,883 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | David Dantzker director | DDisposition to issuer Employee Stock Options (right to buy)derivative | -2,964 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gordon S. Weber Sr. VP of Legal, GC and Sec. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,337 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gary R Maharaj President & CEO | DDisposition to issuer Employee Stock Options (right to buy)derivative | -74,515 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | John D. Manders VP Finance, Corp. Controller | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,584 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Jose H Bedoya director | DDisposition to issuer Employee Stock Options (right to buy)derivative | -2,964 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Lisa Wipperman Heine director | DDisposition to issuer Employee Stock Options (right to buy)derivative | -2,964 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Employee Stock Option (right to buy)derivative | -13,579 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Option (right to buy)derivative | -8,356 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Susan E Knight director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,555 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Joseph J. Stich SVP of HR, President IVD | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,337 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gordon S. Weber Sr. VP of Legal, GC and Sec. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -19,243 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gary R Maharaj President & CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -73,349 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | David Dantzker director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,555 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Employee Stock Options (right to buy)derivative | -17,883 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | John D. Manders VP Finance, Corp. Controller | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,810 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Employee Stock Option (right to buy)derivative | -17,883 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Jose H Bedoya director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,555 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Lisa Wipperman Heine director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,555 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Option (right to buy)derivative | -15,668 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Susan E Knight director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -5,040 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Joseph J. Stich SVP of HR, President IVD | DDisposition to issuer Employee Stock Option (right to buy)derivative | -19,243 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gordon S. Weber Sr. VP of Legal, GC and Sec. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,859 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | David Dantzker director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,674 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gary R Maharaj President & CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -84,669 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,337 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | John D. Manders VP Finance, Corp. Controller | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,160 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,337 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Jose H Bedoya director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,674 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Lisa Wipperman Heine director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,674 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Options (right to buy)derivative | -17,883 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,337 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Susan E Knight director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,155 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Joseph J. Stich SVP of HR, President IVD | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,101 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Gary R Maharaj President & CEO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -89,127 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | David Dantzker director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,853 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Employee Stock Option (right to buy)derivative | -19,243 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,016 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Lisa Wipperman Heine director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,853 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Jose H Bedoya director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -3,853 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Timothy J. Arens Chief Financial Officer | DDisposition to issuer Employee Stock Option (right to buy)derivative | -26,548 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Option (right to buy)derivative | -28,864 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Charles W Olson SVP, Medical Device Coatings | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,101 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 19, 2025 | Teri Woodwick Sides SVP, Vascular Interventions | DDisposition to issuer Employee Stock Option (right to buy)derivative | -29,582 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Feb 18, 2025 | Lisa Wipperman Heine director | MOption exercise Common Stock | +2,640 | $27.30 | $72k | 16,093 | Feb 20, 2025 |
| Feb 18, 2025 | Lisa Wipperman Heine director | FTax withholding Common Stock | -2,115 | $34.09 | $72k | 13,978 | Feb 20, 2025 |
| Feb 18, 2025 | Lisa Wipperman Heine director | MOption exercise Stock Option (right to buy)derivative | -2,640 | $0.00 | $0 | 0 | Feb 20, 2025 |
| Feb 14, 2025 | Jose H Bedoya director | MOption exercise Common Stock | +5,275 | $27.30 | $144k | 34,232 | Feb 18, 2025 |
| Feb 13, 2025 | David Dantzker director | MOption exercise Common Stock | +5,275 | $27.30 | $144k | 44,399 | Feb 18, 2025 |
| Feb 14, 2025 | Jose H Bedoya director | FTax withholding Common Stock | -4,224 | $34.10 | $144k | 30,008 | Feb 18, 2025 |
| Feb 13, 2025 | David Dantzker director | FTax withholding Common Stock | -4,216 | $34.16 | $144k | 40,183 | Feb 18, 2025 |
| Feb 14, 2025 | Jose H Bedoya director | MOption exercise Stock Option (right to buy)derivative | -5,275 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 13, 2025 | David Dantzker director | MOption exercise Stock Option (right to buy)derivative | -5,275 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Jan 24, 2025 | Susan E Knight director | MOption exercise Common Stock | +7,358 | $27.30 | $201k | 42,506 | Jan 28, 2025 |
| Jan 24, 2025 | Susan E Knight director | FTax withholding Common Stock | -5,266 | $38.15 | $201k | 37,240 | Jan 28, 2025 |
| Jan 24, 2025 | Susan E Knight director | MOption exercise Stock Option (right to buy)derivative | -7,358 | $0.00 | $0 | 0 | Jan 28, 2025 |
| Dec 4, 2024 | Timothy J. Arens Chief Financial Officer | FTax withholding Common Stock | -1,265 | $39.91 | $50k | 67,299 | Dec 6, 2024 |
| Dec 4, 2024 | Gary R Maharaj President & CEO | FTax withholding Common Stock | -4,248 | $39.91 | $170k | 192,056 | Dec 6, 2024 |
| Dec 4, 2024 | John D. Manders VP Finance, Corp. Controller | FTax withholding Common Stock | -152 | $39.91 | $6,066 | 8,155 | Dec 6, 2024 |
| Dec 4, 2024 | Charles W Olson SVP, Medical Device Coatings | FTax withholding Common Stock | -959 | $39.91 | $38k | 51,478 | Dec 6, 2024 |
| Dec 4, 2024 | Teri Woodwick Sides SVP, Vascular Interventions | FTax withholding Common Stock | -946 | $39.91 | $38k | 34,703 | Dec 6, 2024 |
| Dec 4, 2024 | Joseph J. Stich SVP of HR, President IVD | FTax withholding Common Stock | -1,034 | $39.91 | $41k | 61,631 | Dec 6, 2024 |
| Dec 4, 2024 | Gordon S. Weber Sr. VP of Legal, GC and Sec. | FTax withholding Common Stock | -668 | $39.91 | $27k | 21,040 | Dec 6, 2024 |
| Nov 30, 2024 | Timothy J. Arens Chief Financial Officer | FTax withholding Common Stock | -1,786 | $39.45 | $70k | 68,564 | Dec 3, 2024 |
| Nov 30, 2024 | Gary R Maharaj President & CEO | FTax withholding Common Stock | -6,470 | $39.45 | $255k | 196,304 | Dec 3, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Timothy J. ArensChief Financial Officer
- Jose H Bedoyadirector
- David Dantzkerdirector
- Lisa Wipperman Heinedirector
- Susan E Knightdirector
- Gary R MaharajPresident & CEO
- John D. MandersVP Finance, Corp. Controller
- Charles W OlsonSVP, Medical Device Coatings
- Teri Woodwick SidesSVP, Vascular Interventions
- Joseph J. StichSVP of HR, President IVD
- Gordon S. WeberSr. VP of Legal, GC and Sec.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.